Predictors of readmission in patients with congestive heart failure;Predictores de rehospitalización en pacientes con insuficiencia cardíaca congestiva

Revista Medica de Chile

Volumn 126, Issue 10, 1998, Pages 1173-1181

  Castro G, Pablo ^a   Bittner, Vera ^a   Villarroel Del P, Luis ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Heart failure congestive; Hospitalizations Patient admission

Indexed keywords

AGED; ARTICLE; CONGESTIVE HEART FAILURE; FEMALE; HOSPITAL READMISSION; HUMAN; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS;

AGED; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; PATIENT READMISSION; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0032174447     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Guidelines of the evaluation and Management of Heart Failure Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committe on Evaluation and Management of Heart Failure). ACC/AHA TASK FORCE REPORT. J Am Coll Cardiol 1995; 26: 1376-98.
2. GHALI J, COOPER R, FORD E. Trends in Hospitalization Rates for Heart Failure in the United States, 1973-1986. Evidence for increasing Population Prevalence. Arch Intern Med 1990; 150: 769-73.
3. KANNEL WB. Epidemiological aspects of heart failure. Cardiol Clin 1989; 7: 1-9.
4. MCKELVIE R, MCCONACHIE D, YUSUF S. Role of angiotensin converting enzyme inhibitors in patients with left ventricular dysfunction and congestive heart failure. Eur Heart J 1994; 15 (Suppl B): 9-13.
5. YUSUF S, THOM T, ABBOT RD. Changes in hypertension treatment and in congestive heart failure mortality in the United States. Hypertension 1989; 13: 174-9.
6. FITZGERALD F, SMITH D, MARTIN D, FREEDMAN JA, KATZ BP. Case manager intervention to reduce readmission. Arch Intern Med 1994; 154: 1721-9.
7. SMITH D, WEINBERGER M, KATZ B. Post discharge care and readmission. Med Care 1988; 26: 699-708.
8. WEINBERGER M, SMITH D, KATZ B, MOORE P. The cost effectiveness of intensive post discharge care. Med Care 1988; 26: 1092-1102.
9. ROSSUM E, FREDERIKS CM, PHILIPSEN H. Effects of preventive home visits to elderly people. BMJ 1993; 307: 27-32.
10. BUSHNELL FK. Self care for congestive heart failure patients. Journal of Gerontological nursing 1992; October: 27-32.
11. TOWNSEND J, PIPER M, FRANK AO, DYER S, NORTH WRS, MEADE TW. Reduction in hospital readmission stay of early patients by a community based hospital discharge scheme: a randomised controlled trial. BMJ 1988; 297: 20-7.
12. BURNS R, NICHOLS L. Factors predicting readmission of older general medicine patients. J Gen Intern Med 1991; 6: 389-93.
13. PHILLIPS R, SAFRAN C, CLEARLY P, DELBANCO T. Predicting emergency readmissions for patients discharged from the medical service of a teaching hospital. J Gen Intern Mecl 1987; 2: 400-5.
14. NAYLOR M, BROOTEN D, JONES R, LAVIZZO-MOUREY R, MEZEY M, PAULY M. Comprehensive discharge planning for the hospitalized elderly. A randomized clinical trial. Ann Intern Med 1994; 120: 999-1006.
15. RICH MW, BECKMAN V, WITENHERG C, LEVEN CL, FREEDLAND KE, CARNEY RM. A multidisciplinary intervention to prevent readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333: 1190-5.
16. GHALI JK, KADAKIA S, COOPER R, FERLINZ J. Precipitating factors leading to descompensation of heart failure. Arch Intern Med 1988; 148: 2013-6.
17. VINSON JM, RICH M, SPERRY JC, SHAH AS, MCNAMARA T. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 1990; 38: 1290-5.
18. PACKER M, LEE WH, KESSLER PD, GOTTLIEB SS, BERNSTEIN JL, KUKIN ML. Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure. Circulation 1987; 75 (suppl 4): 80.
19. LEVINE TB, LEVINE AB, KETEYIAN SJ, NARINS B, LESH M. Reverse remodeling in heart failure with intensification of vasodilatador therapy. Clin Cardiol 1997; 20: 697-702.
20. THE CONSENSUS TRIAL STUDY GROUP. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J MED 1987; 316: 1429-35.
21. THE SOLVD INVESTIGATORS. Effects of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685-91.
22. THE SOLVD INVESTIGATORS. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991; 325: 293-302.
23. COHN JN, ARCHIBALD DG, ZIESCHE S, FRANCIOSA JA, HARSTON WE, TRISTANI FE, ET AL. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans-Administration Cooperative Study. N Engl J Med 1986; 314: 1547-52.
24. COHN JN, JOHNSON G, ZIESCHE S, COOB F, FRANCIS G, TRISTANI F, ET AL. A comparison of enalapril with hidralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303-10.
25. PFEFFER MA, BRAUNWALD E, MOYE LA, BASTA L, BROWN EJ, CUDDY TE, ET AL. On behalf of the SAVE Investigators. Effect of captopril on mortality and morbility in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement trial. N Engl J Med 1992; 327: 669-77.
26. THE ACUTE INFARCTION RAMIPRIL EFFICACY (AIRE) STUDY INVESTIGATORS. Effect of ramipril on mortality and-morbility of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821-88.
27. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction: Gruppo Italiano per lo Studio della Sopravvivenza nell"infarto Miocardico. Lancet 1994; 343: 1115-22.
28. ISIS-4: a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction ISIS-4 (Fourth International Study of Infarct Survival) collaborative Group. Lancet 1995; 345: 669-85.
29. RECTOR T, JOHNSON G, DUNKMAN B, DANIELS G. FARREL L, HENRICK A, ET AL. Evaluations by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life V-HeFT II. Circulation 1993; 87(Suppl VI): 71-77.
30. ROGERS W, JOHNSTONE D, YUSSUF S, WEINER D, GALLAGHER P, BITTNER V, ET AL. Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The studies of left ventricular dysfunction. J Am Coll Cardiol 1994; 23: 393-400.
31. URETSKY BF, YOUNG JB, SHAHIDI FE, YELLEN LG, HARRISON MC, JOLLY MK. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. J Am Coll Cardiol 1993; 22: 955-62.
32. PACKER M, GHEORGHIADE M, YOUNG JB, CONSTANTINI PJ, ADAMS KF, CODY RJ, ET AL. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzime inhibitors RADIANCE Study. N Engl J Med 1993; 329: 1-7.
33. WARD R, GHEORGHIADE M, YOUNG J, URETSKY B. Economic outcomes of withdrawal of digoxin therapy in adult patients with stable congestive heart failure. J Am Coll Cardiol 1995; 26: 93-101.
34. THE DIGITALIS INVESTIGATION GROUP. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-33.
35. PACKER M, BRISTOW M, COHN JN, COLUCCI W, FOWLER M, GILBERT EM, ET AL. For the U.S. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-55.
36. AUSTRALIA-NEW ZEALAND HEART FAILURE RESEARCH COLLABORATIVE GROUP. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet 1997; 349: 375-80.
37. PACKER M, O'CONNOR CM, GHALI JK, PRESSLER ML, CARSON PE, BELKIN RN, ET AL. For The Prospective Randomized Amlodipine Survival Evaluation Study Group. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996; 335: 1107-14.
38. GOLDBERG RJ, MEYER TE. Advances and stagnations in heart failure. Arch Intern Med 1997; 157: 17-9.